140 related articles for article (PubMed ID: 36789877)
1. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability.
Meng X; Cao J; Zheng H; Ma X; Wang Y; Tong Y; Xie S; Lu R; Guo L
Cancer Med; 2023 Apr; 12(8):9738-9748. PubMed ID: 36789877
[TBL] [Abstract][Full Text] [Related]
2. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer.
Tian Y; Liu LL; Guo DM; Wang Y; Zha WH; Li Y; Wu FJ
J Cell Biochem; 2018 Sep; 119(9):7540-7555. PubMed ID: 29904936
[TBL] [Abstract][Full Text] [Related]
3. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
4. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.
Cui S; Li C
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907841
[TBL] [Abstract][Full Text] [Related]
5. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S
J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487
[TBL] [Abstract][Full Text] [Related]
6. Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.
Yan L; Li S; Xu C; Zhao X; Hao B; Li H; Qiao B
Tumour Biol; 2013 Dec; 34(6):4089-100. PubMed ID: 23873098
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M
Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189
[TBL] [Abstract][Full Text] [Related]
8. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
9. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
Yan L; Li Q; Yang J; Qiao B
J Cell Biochem; 2018 Feb; 119(2):1791-1803. PubMed ID: 28799673
[TBL] [Abstract][Full Text] [Related]
10. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide.
Zhang L; Huang H; Deng L; Chu M; Xu L; Fu J; Zhu Y; Zhang X; Liu S; Zhou Z; Wang Y
Toxicology; 2008 Oct; 252(1-3):49-55. PubMed ID: 18723071
[TBL] [Abstract][Full Text] [Related]
11. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
[TBL] [Abstract][Full Text] [Related]
12. The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer.
Chang H; Wang J; Tian Y; Xu J; Gou X; Cheng J
Oncol Rep; 2012 May; 27(5):1353-9. PubMed ID: 22307108
[TBL] [Abstract][Full Text] [Related]
13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
14. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM
PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450
[TBL] [Abstract][Full Text] [Related]
15. Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma.
Li B; Qi XQ; Chen X; Huang X; Liu GY; Chen HR; Huang CG; Luo C; Lu YC
Brain Res; 2010 Sep; 1352():200-7. PubMed ID: 20599806
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z
Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162
[TBL] [Abstract][Full Text] [Related]
17. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
Yang X; Liu G; Xiao H; Yu F; Xiang X; Lu Y; Li W; Liu X; Li S; Shi Y
Pathol Oncol Res; 2014 Jul; 20(3):641-8. PubMed ID: 24488334
[TBL] [Abstract][Full Text] [Related]
18. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
Zou Z; Zheng B; Li J; Lv X; Zhang H; Yu F; Kong L; Li Y; Yu M; Fang L; Liang B
Biomed Pharmacother; 2018 Nov; 107():1286-1293. PubMed ID: 30257343
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
20. TPX2 regulates tumor growth in human cervical carcinoma cells.
Jiang P; Shen K; Wang X; Song H; Yue Y; Liu T
Mol Med Rep; 2014 Jun; 9(6):2347-51. PubMed ID: 24718984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]